Journal article

Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307

Gregory L Krauss, Emilio Perucca, Patrick Kwan, Elinor Ben-Menachem, Xue-Feng Wang, Jerry J Shih, Anna Patten, Haichen Yang, Betsy Williams, Antonio Laurenza

Epilepsia | WILEY | Published : 2018